Cancer Health Treatment Update
Weight-Loss Meds Reduce Risk of Obesity-Related Cancers

People who used GLP-1 receptor agonists like Ozempic had a modestly lower risk for obesity-related malignancies, especially colon and rectal cancer.

Advertisement
Meet This Year's Cancer Health 25: A Salute to Patient Advocates

Patient advocates provide support, education, prevention, treatment, care and more, especially for the poor, marginalized and underinsured.

Cancer Health Summer 2025

Check out our new print edition!

FDA Approves Ibtrozi for ROS1-Positive Lung Cancer

About 90% of previously untreated people who received the oral targeted therapy experienced tumor regression.

Imfinzi Immunotherapy Plus Chemotherapy Reduces Risk of Stomach Cancer Progression

Treatment before and after surgery led to longer survival without cancer recurrence or progression patients with operable gastric cancer.

News From the ASCO Annual Meeting

Reports on cancer prevention, care and treatment from the American Society of Clinical Oncology annual meeting in Chicago.

As Cannabis Users Age, Health Risks Appear to Grow

National survey data show 7% of adults age 65 or older reported recent cannabis use, including cancer patients who use it to promote appetite or relieve pain.

‘We Dissent’: NIH Workers Protest Trump Policies That ‘Harm the Health of Americans’

The letter is an extraordinary rebuke of the Trump administration’s actions, which include terminating hundreds of research grants.


You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2025 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.